Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo.
about
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell linesIrinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil.Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent mannerCombination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancerFOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts.Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients.Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell linesMulticentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX.A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice.Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay.The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells.CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.DeepSynergy: Predicting anti-cancer drug synergy with Deep Learning.Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
P2860
Q28350941-A977386A-2C28-4B67-8A4D-3ED1DCEDAB30Q34342186-ABD99664-AB22-4406-962E-978E68D7EC98Q34693012-DFBEB2FF-9C05-46B7-A554-60993DB0C65FQ35076861-C9F81351-8D25-4877-BBB2-AF3B6B37F17DQ35091427-DE7B810B-944C-4577-980B-76D7208D0B17Q35779961-981BB7A4-89F3-48FC-96C1-BBE55472238AQ36058012-4BC718A4-AABC-4ED0-90CB-70F26D82F82AQ36214563-8D178768-55D0-4CB4-8616-1111BD7BFDC2Q36610474-312D6C6A-DED4-4E45-AE2E-94AECB5237D6Q36614623-ED2B797B-8477-4299-8857-FBC1883E8A92Q36616217-03F5CA27-A46F-40F8-AB1E-022E3996794CQ36695803-A585C753-356E-4A63-95A4-DA6B6993A03AQ37702324-BA6895B1-9F33-4EBC-90F7-49D1A14CF1E1Q40036736-B8477BCA-37C0-44AA-87CE-BD48C8891760Q40424136-8952F4F0-E24C-4AD0-AB74-6175FCD41668Q43619712-22437C72-A176-4886-B02C-6384579AB77AQ47290651-B8757E28-C95A-42DE-B1F1-E0509D16813FQ53440447-5CB8FB40-3F1B-42B4-964D-52845051210E
P2860
Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Sequence-dependent activity of ...... el HT-29 in vitro and in vivo.
@en
type
label
Sequence-dependent activity of ...... el HT-29 in vitro and in vivo.
@en
prefLabel
Sequence-dependent activity of ...... el HT-29 in vitro and in vivo.
@en
P2093
P2860
P1476
Sequence-dependent activity of ...... el HT-29 in vitro and in vivo.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19971127)73:5<729::AID-IJC20>3.0.CO;2-#
P577
1997-11-01T00:00:00Z